Company: INDP
Filing Date: 2025-03-13
Form Type: 10-K
Source: 0001493152-25-010136
Chunk: 78

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-03-13
Form: 10-K
Item: Item 1
Chunk 78
---
 and resolve
and would divert our management and scientific personnel’s time and attention.

Changes
in U.S. patent law could diminish the value of patents in general, thereby impairing our ability to protect our products.

As
is the case with other biotechnology companies, our success is heavily dependent on intellectual property, particularly patents. Obtaining
and enforcing patents in the biotechnology industry involves both technological and legal complexity and is costly, time-consuming and
inherently uncertain. For example, the U.S. previously enacted and is currently implementing wide-ranging patent reform legislation.
Specifically, on September 16, 2011, the Leahy-Smith America Invents Act, or the Leahy-Smith Act, was signed into law and included a
number of significant changes to U.S. patent law, and many of the provisions became effective in March 2013. However, it may take the
courts years to interpret the provisions of the Leahy-Smith Act, and the implementation of the statute could increase the uncertainties
and costs surrounding the prosecution of our licensed and future patent applications and the enforcement or defense of our licensed and
future patents, all of which could have a material adverse effect on our business, financial condition and results of operations.

In
addition, the U.S. Supreme Court has ruled on several patent cases in recent years, either narrowing the scope of patent protection available
in certain circumstances or weakening the rights of patent owners in certain situations. In addition to increasing uncertainty with regard
to our ability to obtain patents in the future, this combination of events has created uncertainty with respect to the value of patents,
once obtained. Depending on decisions by the U.S. Congress, the federal courts and the USPTO, the laws and regulations governing patents
could change in unpredictable ways that would weaken our ability to obtain new patents or to enforce patents that we might obtain in
the future.

We
may not be able to protect our intellectual property rights throughout the world.

Filing,
prosecuting and defending patents on product candidates throughout the world could be prohibitively expensive. Competitors may use our
licensed and owned technologies in jurisdictions where we have not licensed or obtained patent protection to develop their own products
and, further, may export otherwise infringing products to territories where we may obtain or license patent protection, but where patent
enforcement is not as strong as that in the U.S. These products may compete with our products in jurisdictions where we do not have any
issued or licensed patents and any future patent claims